AOP Orphan Pharmaceuticals GmbH
2 products tracked · names used in filings: AOP Orphan Pharmaceuticals GmbH
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Sugammadex Amomed sugammadex | Authorised | 2023-01-10 |
| 🇪🇺 | Besremi ropeginterferon alfa-2b | Authorised | 2019-02-15 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.